tiprankstipranks
Advertisement
Advertisement

CGEM Stock Latest News

Cullinan post-EULAR share pullback ‘unwarranted,’ says Clear Street
The FlyCullinan post-EULAR share pullback ‘unwarranted,’ says Clear Street
2d ago
CGEM
Cullinan Therapeutics receives orphan drug designation for CLN-049
PremiumThe Fly
Cullinan Therapeutics receives orphan drug designation for CLN-049
3d ago
CGEM
Cullinan Management Shares Promising Early CLN-978 Autoimmune Data
PremiumCompany Announcements
Cullinan Management Shares Promising Early CLN-978 Autoimmune Data
3d ago
8K
CGEM
Cullinan Therapeutics price target raised to $37 from $36 at Wedbush
PremiumThe Fly
Cullinan Therapeutics price target raised to $37 from $36 at Wedbush
14d ago
CGEM
Cullinan Therapeutics reports Q1 EPS (75c), consensus (85c)
PremiumThe Fly
Cullinan Therapeutics reports Q1 EPS (75c), consensus (85c)
15d ago
CGEM
Cullinan jumps after UCB acquires Candid Therapeutics
PremiumThe FlyCullinan jumps after UCB acquires Candid Therapeutics
18d ago
CGEM
Cullinan Oncology: FDA Acceptance of Zipalertinib NDA and Upcoming CLN-978 Data Underpin Buy Rating and Favorable NPV Outlook
Premium
Ratings
Cullinan Oncology: FDA Acceptance of Zipalertinib NDA and Upcoming CLN-978 Data Underpin Buy Rating and Favorable NPV Outlook
23d ago
CGEM
Cullinan Therapeutics price target raised to $30 from $27 at H.C. Wainwright
Premium
The Fly
Cullinan Therapeutics price target raised to $30 from $27 at H.C. Wainwright
24d ago
CGEM
Cullinan Therapeutics announces U.S. FDA accepted NDA for zipalertinib
PremiumThe Fly
Cullinan Therapeutics announces U.S. FDA accepted NDA for zipalertinib
24d ago
CGEM
Clear Street says Gilead-Ouro deal highlights upside for Cullinan’s velinotamig
PremiumThe Fly
Clear Street says Gilead-Ouro deal highlights upside for Cullinan’s velinotamig
2M ago
CGEM
GILD
Cullinan Therapeutics price target raised to $36 from $34 at Wedbush
PremiumThe Fly
Cullinan Therapeutics price target raised to $36 from $34 at Wedbush
2M ago
CGEM
Cullinan: Advancing Immunology and Oncology Pipeline Undervalued; Buy Rating on CLN-978 Catalysts and Strong Cash Runway
PremiumRatings
Cullinan: Advancing Immunology and Oncology Pipeline Undervalued; Buy Rating on CLN-978 Catalysts and Strong Cash Runway
2M ago
CGEM
Cullinan Management Adopts Reduced SEC Reporting: Lower Compliance Costs, But Potential Hit to Investor Appeal and Liquidity
PremiumCompany AnnouncementsCullinan Management Adopts Reduced SEC Reporting: Lower Compliance Costs, But Potential Hit to Investor Appeal and Liquidity
2M ago
CGEM
Cullinan Therapeutics reports Q4 EPS (77c), consensus (84c)
Premium
The Fly
Cullinan Therapeutics reports Q4 EPS (77c), consensus (84c)
2M ago
CGEM
Cullinan Therapeutics sees cash runway into 2029
Premium
The Fly
Cullinan Therapeutics sees cash runway into 2029
2M ago
CGEM
CGEM Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CGEM Upcoming Earnings Report: What to Expect?
3M ago
CGEM
TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
PremiumMarket News
TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
3M ago
CL
CAT
Cullinan Therapeutics initiated with a Buy at Citi
PremiumThe Fly
Cullinan Therapeutics initiated with a Buy at Citi
3M ago
CGEM
Cullinan Oncology: Undervalued Autoimmune Pipeline With 2026 CLN-978 Catalysts and Additional Oncology Upside Supporting Buy Rating
PremiumRatings
Cullinan Oncology: Undervalued Autoimmune Pipeline With 2026 CLN-978 Catalysts and Additional Oncology Upside Supporting Buy Rating
3M ago
CGEM
TheStreet Pro Analysts Say, “Big Tech Names are Anything But Cheap – Buy These 2 Stocks Instead”
PremiumMarket NewsTheStreet Pro Analysts Say, “Big Tech Names are Anything But Cheap – Buy These 2 Stocks Instead”
4M ago
KO
KMB
Cullinan Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Cullinan Therapeutics initiated with a Buy at Guggenheim
4M ago
CGEM
Cullinan Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Cullinan Therapeutics initiated with a Buy at Guggenheim
4M ago
CGEM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >